$EYEG EYEGATE PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in EYEGATE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EYEGATE PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in EYEGATE PHARMACEUTICALS INC for free.
CIK Number: 0001372514
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EYEG
Company Address: 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM 02452
Phone number: 781-788-9043
Market Capitalization: $15.24M
Prev close: $1.58
Average Daily Volume: 330,737
Days Low: $1.53
Year Low: $1.11
Year High: $5.10
EYEGATE PHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | EYEG | EYEGATE PHARMACEUT ... | FROM STEPHEN | Executive Chairman | Payment of Exercise | F | 4.13 | 889 | 3,672 | 71,060 | 71.9 K to 71.1 K (-1.24 %) |
May 05 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 4.13 | 177 | 731 | 23,756 | 23.9 K to 23.8 K (-0.74 %) |
May 05 2021 | EYEG | EYEGATE PHARMACEUT ... | MANZO MICHAEL P. | VP of Engineering | Payment of Exercise | F | 4.13 | 158 | 653 | 15,758 | 15.9 K to 15.8 K (-0.99 %) |
May 05 2021 | EYEG | EYEGATE PHARMACEUT ... | Mann Brenda | VP of Research & De ... | Payment of Exercise | F | 4.13 | 191 | 789 | 15,693 | 15.9 K to 15.7 K (-1.20 %) |
Apr 21 2021 | EYEG | EYEGATE PHARMACEUT ... | Gayron Kenneth L | Director | Option Exercise | A | 4.40 | 4,000 | 17,600 | 4,000 | |
Apr 21 2021 | EYEG | EYEGATE PHARMACEUT ... | Shapiro Aron | Director | Option Exercise | A | 4.40 | 4,000 | 17,600 | 4,000 | |
Apr 09 2021 | EYEG | EYEGATE PHARMACEUT ... | FROM STEPHEN | Executive Chairman | Payment of Exercise | F | 4.94 | 899 | 4,441 | 71,949 | 72.8 K to 71.9 K (-1.23 %) |
Apr 09 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 4.94 | 180 | 889 | 23,933 | 24.1 K to 23.9 K (-0.75 %) |
Apr 09 2021 | EYEG | EYEGATE PHARMACEUT ... | MANZO MICHAEL P. | VP of Engineering | Payment of Exercise | F | 4.94 | 194 | 958 | 15,916 | 16.1 K to 15.9 K (-1.20 %) |
Apr 09 2021 | EYEG | EYEGATE PHARMACEUT ... | Mann Brenda | VP of Research & De ... | Payment of Exercise | F | 4.94 | 192 | 948 | 15,884 | 16.1 K to 15.9 K (-1.19 %) |
Mar 05 2021 | EYEG | EYEGATE PHARMACEUT ... | FROM STEPHEN | Executive Chairman | Payment of Exercise | F | 5.46 | 898 | 4,903 | 72,848 | 73.7 K to 72.8 K (-1.22 %) |
Mar 05 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 5.46 | 218 | 1,190 | 24,113 | 24.3 K to 24.1 K (-0.90 %) |
Mar 05 2021 | EYEG | EYEGATE PHARMACEUT ... | MANZO MICHAEL P. | VP of Engineering | Payment of Exercise | F | 5.46 | 192 | 1,048 | 16,110 | 16.3 K to 16.1 K (-1.18 %) |
Mar 05 2021 | EYEG | EYEGATE PHARMACEUT ... | Mann Brenda | VP of Research & De ... | Payment of Exercise | F | 5.46 | 192 | 1,048 | 16,076 | 16.3 K to 16.1 K (-1.18 %) |
Feb 03 2021 | EYEG | EYEGATE PHARMACEUT ... | MANZO MICHAEL P. | VP of Engineering | Option Exercise | A | 6.46 | 10,000 | 64,600 | 10,000 |